Webinars

PELOAcademy | Live-cell imaging and gene editing technologies in cell culture

presented by Dr. Severin Mühleder, Bartelt GmbH, Austria

Recent advances in live-cell imaging and gene editing are transforming the way researchers investigate cellular processes in vitro. These technologies provide scientists with powerful new tools to study biological mechanisms and develop more informative cell culture models. In this webinar, Dr. Mühleder will provide an overview of current approaches and emerging trends in live-cell imaging and gene editing, highlighting how these technologies can be integrated into modern cell culture workflows.

Is There an Optimal Enzyme Dose for Human Islet Isolation?

presented by Appakalai N. Balamurugan, University of Louisville; Robert McCarthy, Mike Green, VitaCyte; Doug O’Gorman, Gift of Life Alberta, USA
 
This webinar brings together leading experts to discuss how collagenase–protease enzyme mixtures are dosed for human islet isolation, from the development of Liberase HI to tissue-weight-based dosing strategies and design-of-experiment approaches with recombinant collagenases. The session will explore how collagenase class I, class II and neutral protease influence islet yield, function and recovery after short-term culture.

PELOAcademy | The CELLenger: Bringing flow into standard cell culture

presented by Dr. Steffen Winkler, University Augsburg
 
Controlled flow is essential for in vitro models that reflect human physiology — yet flow-based cell culture often remains out of reach due to its complexity, cost, and required expertise. This live-only-webinar presents the CELLenger, a smart cell culture plate that makes perfusion accessible — from first-time users to labs running advanced 3D and barrier models. We will outline the scientific concept, show the device in action, and discuss applications from vascular to perfused 3D cultures. There will be no recording this time, so sign up!

PELOAcademy | Vascularized 3D cell culture systems: Endothelial Cells in focus

presented by Dr. Severin Mühleder, Bartelt GmbH, Austria

This webinar will discuss current challenges associated with endothelial cell use in in vitro vascularization strategies. The limitations of commonly used sources will be addressed, including donor-to-donor variability and the consequences for reproducibility and biological interpretation. Furthermore, the representation of vascular diversity across tissues and populations will be considered as an important factor in building biologically representative in vitro models.

PELOAcademy | Unlocking potential with serum-free, animal-free and chemically defined media

presented by Dr. Lothar Steeb, CEO/ CSO, PELOBiotech
 
The future of cell culture is here: free from animal-derived components, yet richer in performance. Join us to explore how serum-free, animal-free, and chemically defined media are revolutionizing bioprocessing, from research to scalable production. Discover Cellovations® solutions, case studies and practical strategies to transition seamlessly while maintaining cell viability & productivity.

Overcoming the Challenges of Islet Recovery from Young Donor Pancreases: An Update 5 Years Later

presented by Appakalai N. Balamurugan, PhD, Professor, Pediatric Endocrinology Director, Islet Biology & Transplantation, University of Louisville, USA
 

Discover how enzyme composition directly impacts islet quality and recovery in young donor pancreata, with new data showing clear advantages of increased protease formulations. Join this talk to see why IPC-based digestion—validated across intact organs using mixtures from VitaCyte, Roche, and Nordmark—may redefine best practices in islet isolation.

ISO 20399 Standard for Ancillary Materials: Relevance to Tissue Dissociation Enzymes

presented by Robert McCarthy, PhD, CEO, VitaCyte
 
A case study will be presented demonstrating how the biochemical characteristics of collagenase enzymes affected human islet yields, leading to fewer islet transplants in 2007 as part of the Clinical Islet Transplantation Consortium clinical trial.

PELOAcademy | Lisado de Plaquetas Humanas – Productos Clave para la Investigación con Células Madre Mesenquimales (MSCs)

presented by Dr. Julian Olmos, International Sales Manager PELOBiotech

Lisado de Plaquetas Humanas – Productos Clave para la Investigación con Células Madre Mesenquimales (MSCs)

PELOAcademy | Lizat płytek krwi ludzkiej – kluczowe produkty do badań nad MSCs

presented by Dr. Julian Olmos, International Sales Manager PELOBiotech

Lizat płytek krwi ludzkiej – kluczowe produkty do badań nad MSCs

PELOAcademy | Organ-on-Chip: Next-Gen human models for drug research

presented by Dr. Madalena Cipriano and Dr. Silke Riegger, 3R Network Tübingen

Highlighting how Organ-on-Chip technology is transforming pharmaceutical research and paving the way for personalized medicine through advanced human model systems.

PELOAcademy | Organoids: Insights into Cancer Treatment

presented by Dr. Ralf Horres, CEO GenXPro, Frankfurt
Exploring how organoid technology is revolutionizing cancer research and therapy.

Discover how these 3D cellular models are being used to simulate tumor environments, test personalized treatments, and accelerate drug discovery.

PELOAcademy | EVs Unpacked: Innovative Tools for Extracellular Vesicle Isolation

presented by Prof. Dr. Irina Nazarenko, UK Freiburg

Recording will be available after June 2025

We present a workflow combining high-purity EV isolation, a software for standardized size and concentration analysis across different instruments, and the new Protein Interaction Coupling assay for absolute biomarker quantification at the single-vesicle level directly in a reaction tube. The result: accessible, scalable solution advancing EV-based liquid biopsy&precision medicine.

PELOAcademy | Cardiac Organoids: From Generation to Application

Presented by Dr. Seon-In Hwang, leader of organoid team at Nexel Co., Seoul, South Korea

This webinar will highlight a 3D cardiac organoid platform developed using human iPSCs to accelerate the functional maturation of cardiomyocytes. The system enhances electrophysiological performance and contractility through multicellular organization and three-dimensional culture conditions. The study supports the platform’s potential use in cardiac toxicity screening, disease modeling, and preclinical applications. No recording available.

PELOAcademy | Human-based biomaterials: The missing link for more predictive 3D Cell Culture

Presented by Dr. Ana Rufino, Senior Researcher, Metatissue, Portugal

We present human protein-derived alternatives, focusing on human methacryloyl platelet lysates (hPLMA), a fully human, tunable biomaterial that overcomes the limits of conventional ECM substitutes. hPLMA-based scaffolds (hydrogels, sponges, microparticles) enable FBS-free culture, maintaining cell viability, proliferation, and differentiation across various cell types.

PELOAcademy | Scaled MSC Cultivation for EV Production using CDM-Challenges and Pitfalls

Presented by Dr. Tanja Kutzner, UK Essen

This webinar explores the journey to GMP-compliant EV manufacturing using clonally immortalized MSCs (ciMSCs). Tanja shares insights on CDM vs. hPL media, challenges in 2D and 3D culture transitions, and key hurdles in EV production, scale-up, and purification. Learn the lessons, pitfalls, and practical strategies from real-world CDM-based EV production.

Role of Nav1.8 Channels in Regulating Excitability of Human DRG Neurons Studied Using Suzetrigine

Presented by Dr. Bruce Bean, Ph.D. Professor of Neurobiology at Harvard Medical School, US

Dr. Bean will present recent findings on the selective Nav1.8 inhibitor, suzetrigine (Journavx), exploring its state- and temperature-dependent effects on neuronal activity. The session will highlight how suzetrigine influences action potential firing and refractory periods at physiological temperatures, offering key insights into the mechanisms of acute pain and the therapeutic potential of targeting Nav1.8 for clinical pain management.

Human-Relevant Vascularized Tissue Models

Presented by James B. Hoying, PhD, Partner and Chief Scientist at Advanced Solutions Life Sciences (ASLS), US and our partner VitaCyte

Date & Time: Thurs, June 19, 25 | 5 PM CEST/11 AM ET

This webinar will explore some of these concepts and avenues by which advanced human-relevant tissue models are employed. An overview of cell sourcing for these models, including vascularization solutions, will be discussed while highlighting solutions to readily build and deploy complex, vascularized tissues for human-relevant tissue modeling and regenerative therapies.

Challenges Facing the Isolation of High-Quality Islets for Total Pancreatectomy with Islet Autotransplantation

Presented by Bashoo Naziruddin, PhD, Director of islet cell processing lab at Baylor UMC Dallas, USA, and our partner VitaCyte

This presentation will highlight the recent progress made by our team in the field of TPIAT with emphasis on the identification of biomarkers for the prediction of good islet yield from the inflamed pancreas and favorable endocrine function during the post-transplant period.

PELOAcademy | How the choice of medium affects your research

Presented by Dr. Lothar Steeb, CEO&CSO PELOBiotech

Join us for a comprehensive overview of various types of cell culture media, their composition, and their applications in research and industry. Understanding the right culture medium is essential for optimizing cell growth, viability, and experimental outcomes.

PELOBiotech | Presentación de la empresa - (en Espanol)

Presented by Dr. Julian Olmos, PELOBiotech

Este webinario está dedicado al mercado español, el Dr. Janna Olmos presentará la empresa, las distintas gamas de productos, y como PELOBiotech puede ayudarle con sus necesidades científicas tanto a nivel de I + D como a nivel clínico y farmacéutico.

PELOAcademy | Animals in the (Petri) dish: Towards a truly animal-free laboratory

Presented by Tilo Weber, Deutscher Tierschutzbund e.V./Academy for Animal Welfare of the German Animal Welfare Federation

Accurate laboratory results are crucial for cell cultures but are hindered by undefined, animal-derived materials like fetal bovine serum, Accutase, and Matrigel. These pose reproducibility, safety, and ethical challenges.

This talk highlights these issues and presents animal-free alternatives to enhance reliability and reproducibility in cell and tissue cultures.

PELOBiotech | Presentazione dell'azienda

Presented by Leonardo Basso, PELOBiotech, in Italiano

PELOBiotech GmbH è un’azienda specializzata nello sviluppo e nella fornitura di soluzioni per la ricerca cellulare. Con uno dei più ampi portafogli di prodotti al mondo, offre cellule primarie, terreni di coltura, sistemi 3D e soluzioni personalizzate per diversi ambiti della ricerca biomedica. Grazie a collaborazioni con fornitori internazionali di alto livello, PELOBiotech garantisce materiali di alta qualità, inclusi prodotti GMP-compliant per applicazioni avanzate come la medicina rigenerativa e la terapia cellulare. Con questo webinar dedicato al mercato italiano Dr. Leonardo Basso presenterà l’azienda, le varie fasce di prodotti, come collaborare con PELOBiotech e risponderà alle vostre domande.

PELOAcademy | Mycoplasma in Cell Culture: Prevention, Detection, Elimination

Presented by Prof. Dr. Gerhard Gstraunthaler, med. Universität Innsbruck (ret.), Austria

This webinar will help us understand the biology of mycoplasma, its sources of contamination, and the safety concerns it poses in cell culture. We'll discuss the effects of mycoplasma on cultured cells, methods for detection, and practical strategies for prevention and elimination. Gain essential insights to maintain the safety and integrity of your cell cultures.

Therefore, routine testing for mycoplasma is of critical importance. In this webinar we will talk about - the biology of mycoplasma - the source of contaminations and safety aspects - the effects on cultured cells - methodes of testing - prevention and elimination

PELOBiotech: Presentazione dell'azienda

Presented by Leonardo Basso, PELOBiotech, in Italiano

PELOBiotech GmbH è un’azienda specializzata nello sviluppo e nella fornitura di soluzioni per la ricerca cellulare. Con uno dei più ampi portafogli di prodotti al mondo, offre cellule primarie, terreni di coltura, sistemi 3D e soluzioni personalizzate per diversi ambiti della ricerca biomedica. Grazie a collaborazioni con fornitori internazionali di alto livello, PELOBiotech garantisce materiali di alta qualità, inclusi prodotti GMP-compliant per applicazioni avanzate come la medicina rigenerativa e la terapia cellulare.

Con questo webinar dedicato al mercato italiano Dr. Leonardo Basso presenterà l’azienda, le varie fasce di prodotti, come collaborare con PELOBiotech e risponderà alle vostre domande.